Conjugates of modified cryptophycins and RGD-peptides enter target cells by endocytosis
Nahrwold M, Weiß C, Bogner T, Mertink F, Conradi J, Sammet B, Palmisano R, Royo Gracia S, Preusse T, Sewald N (2013)
Journal of Medicinal Chemistry 56(5): 1853-1864.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Nahrwold, Markus;
Weiß, ChristineUniBi;
Bogner, TobiasUniBi;
Mertink, FelixUniBi;
Conradi, JensUniBi;
Sammet, BenediktUniBi;
Palmisano, Ralf;
Royo Gracia, Soledad;
Preusse, ThomasUniBi;
Sewald, NorbertUniBi
Einrichtung
Abstract / Bemerkung
Tumor targeting anticancer drug conjugates that contain a tumor recognition motif (homing device) are of high current relevance. Cryptophycins, naturally occurring cytotoxic cyclo-depsipeptides, have been modified by total synthesis to provide analogues suitable for conjugation to peptide-based homing devices. An array of functionalized β(2)-amino acids was synthesized and incorporated into cryptophycins. All analogues proved to be highly active in the cytotoxicity assay using the human cervix carcinoma cell line KB-3-1 and its multidrug-resistant subclone KB-V1. Conformational analysis of cryptophycin-52 and two synthetic analogues was performed by NMR and MD methods to obtain information on the influence of the unit C configuration on the overall conformation. An azide-functionalized cryptophycin was connected by CuAAC to an alkyne-containing fluorescently labeled cyclic RGD-peptide as the homing device for internalization studies. Confocal fluorescence microscopy proved integrin-mediated internalization by endocytosis and final lysosomal localization of the cryptophycin prodrug.
Erscheinungsjahr
2013
Zeitschriftentitel
Journal of Medicinal Chemistry
Band
56
Ausgabe
5
Seite(n)
1853-1864
ISSN
0022-2623
eISSN
1520-4804
Page URI
https://pub.uni-bielefeld.de/record/2579007
Zitieren
Nahrwold M, Weiß C, Bogner T, et al. Conjugates of modified cryptophycins and RGD-peptides enter target cells by endocytosis. Journal of Medicinal Chemistry. 2013;56(5):1853-1864.
Nahrwold, M., Weiß, C., Bogner, T., Mertink, F., Conradi, J., Sammet, B., Palmisano, R., et al. (2013). Conjugates of modified cryptophycins and RGD-peptides enter target cells by endocytosis. Journal of Medicinal Chemistry, 56(5), 1853-1864. https://doi.org/10.1021/jm301346z
Nahrwold, Markus, Weiß, Christine, Bogner, Tobias, Mertink, Felix, Conradi, Jens, Sammet, Benedikt, Palmisano, Ralf, Royo Gracia, Soledad, Preusse, Thomas, and Sewald, Norbert. 2013. “Conjugates of modified cryptophycins and RGD-peptides enter target cells by endocytosis”. Journal of Medicinal Chemistry 56 (5): 1853-1864.
Nahrwold, M., Weiß, C., Bogner, T., Mertink, F., Conradi, J., Sammet, B., Palmisano, R., Royo Gracia, S., Preusse, T., and Sewald, N. (2013). Conjugates of modified cryptophycins and RGD-peptides enter target cells by endocytosis. Journal of Medicinal Chemistry 56, 1853-1864.
Nahrwold, M., et al., 2013. Conjugates of modified cryptophycins and RGD-peptides enter target cells by endocytosis. Journal of Medicinal Chemistry, 56(5), p 1853-1864.
M. Nahrwold, et al., “Conjugates of modified cryptophycins and RGD-peptides enter target cells by endocytosis”, Journal of Medicinal Chemistry, vol. 56, 2013, pp. 1853-1864.
Nahrwold, M., Weiß, C., Bogner, T., Mertink, F., Conradi, J., Sammet, B., Palmisano, R., Royo Gracia, S., Preusse, T., Sewald, N.: Conjugates of modified cryptophycins and RGD-peptides enter target cells by endocytosis. Journal of Medicinal Chemistry. 56, 1853-1864 (2013).
Nahrwold, Markus, Weiß, Christine, Bogner, Tobias, Mertink, Felix, Conradi, Jens, Sammet, Benedikt, Palmisano, Ralf, Royo Gracia, Soledad, Preusse, Thomas, and Sewald, Norbert. “Conjugates of modified cryptophycins and RGD-peptides enter target cells by endocytosis”. Journal of Medicinal Chemistry 56.5 (2013): 1853-1864.
Daten bereitgestellt von European Bioinformatics Institute (EBI)
CHEMBL
18 Einträge gefunden, die diesen Artikel zitieren von denen 10 angezeigt werden
21 Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
Neutrophil Elastase Promotes Linker Cleavage and Paclitaxel Release from an Integrin-Targeted Conjugate.
Raposo Moreira Dias A, Pina A, Dean A, Lerchen HG, Caruso M, Gasparri F, Fraietta I, Troiani S, Arosio D, Belvisi L, Pignataro L, Dal Corso A, Gennari C., Chemistry 25(7), 2019
PMID: 30452790
Raposo Moreira Dias A, Pina A, Dean A, Lerchen HG, Caruso M, Gasparri F, Fraietta I, Troiani S, Arosio D, Belvisi L, Pignataro L, Dal Corso A, Gennari C., Chemistry 25(7), 2019
PMID: 30452790
Synthesis and Biological Evaluation of RGD⁻Cryptophycin Conjugates for Targeted Drug Delivery.
Borbély A, Figueras E, Martins A, Esposito S, Auciello G, Monteagudo E, Di Marco A, Summa V, Cordella P, Perego R, Kemker I, Frese M, Gallinari P, Steinkühler C, Sewald N., Pharmaceutics 11(4), 2019
PMID: 30939768
Borbély A, Figueras E, Martins A, Esposito S, Auciello G, Monteagudo E, Di Marco A, Summa V, Cordella P, Perego R, Kemker I, Frese M, Gallinari P, Steinkühler C, Sewald N., Pharmaceutics 11(4), 2019
PMID: 30939768
Octreotide Conjugates for Tumor Targeting and Imaging.
Figueras E, Martins A, Borbély A, Le Joncour V, Cordella P, Perego R, Modena D, Pagani P, Esposito S, Auciello G, Frese M, Gallinari P, Laakkonen P, Steinkühler C, Sewald N., Pharmaceutics 11(5), 2019
PMID: 31067748
Figueras E, Martins A, Borbély A, Le Joncour V, Cordella P, Perego R, Modena D, Pagani P, Esposito S, Auciello G, Frese M, Gallinari P, Laakkonen P, Steinkühler C, Sewald N., Pharmaceutics 11(5), 2019
PMID: 31067748
Conjugates of Cryptophycin and RGD or isoDGR Peptidomimetics for Targeted Drug Delivery.
Borbély A, Figueras E, Martins A, Bodero L, Raposo Moreira Dias A, López Rivas P, Pina A, Arosio D, Gallinari P, Frese M, Steinkühler C, Gennari C, Piarulli U, Sewald N., ChemistryOpen 8(6), 2019
PMID: 31275795
Borbély A, Figueras E, Martins A, Bodero L, Raposo Moreira Dias A, López Rivas P, Pina A, Arosio D, Gallinari P, Frese M, Steinkühler C, Gennari C, Piarulli U, Sewald N., ChemistryOpen 8(6), 2019
PMID: 31275795
Novel unit B cryptophycin analogues as payloads for targeted therapy.
Figueras E, Borbély A, Ismail M, Frese M, Sewald N., Beilstein J Org Chem 14(), 2018
PMID: 29977395
Figueras E, Borbély A, Ismail M, Frese M, Sewald N., Beilstein J Org Chem 14(), 2018
PMID: 29977395
Cancer-targeted delivery systems based on peptides.
Chatzisideri T, Leonidis G, Sarli V., Future Med Chem 10(18), 2018
PMID: 30043641
Chatzisideri T, Leonidis G, Sarli V., Future Med Chem 10(18), 2018
PMID: 30043641
In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas.
Cazzamalli S, Figueras E, Pethő L, Borbély A, Steinkühler C, Neri D, Sewald N., ACS Omega 3(11), 2018
PMID: 30533574
Cazzamalli S, Figueras E, Pethő L, Borbély A, Steinkühler C, Neri D, Sewald N., ACS Omega 3(11), 2018
PMID: 30533574
Intelligent substance delivery into cells using cell-penetrating peptides.
Tashima T., Bioorg Med Chem Lett 27(2), 2017
PMID: 27956345
Tashima T., Bioorg Med Chem Lett 27(2), 2017
PMID: 27956345
RGD-mediated delivery of small-molecule drugs.
Katsamakas S, Chatzisideri T, Thysiadis S, Sarli V., Future Med Chem 9(6), 2017
PMID: 28394627
Katsamakas S, Chatzisideri T, Thysiadis S, Sarli V., Future Med Chem 9(6), 2017
PMID: 28394627
Tumor Targeting with an isoDGR-Drug Conjugate.
Zanella S, Angerani S, Pina A, López Rivas P, Giannini C, Panzeri S, Arosio D, Caruso M, Gasparri F, Fraietta I, Albanese C, Marsiglio A, Pignataro L, Belvisi L, Piarulli U, Gennari C., Chemistry 23(33), 2017
PMID: 28449309
Zanella S, Angerani S, Pina A, López Rivas P, Giannini C, Panzeri S, Arosio D, Caruso M, Gasparri F, Fraietta I, Albanese C, Marsiglio A, Pignataro L, Belvisi L, Piarulli U, Gennari C., Chemistry 23(33), 2017
PMID: 28449309
Cryptophycins: cytotoxic cyclodepsipeptides with potential for tumor targeting.
Weiss C, Figueras E, Borbely AN, Sewald N., J Pept Sci 23(7-8), 2017
PMID: 28661555
Weiss C, Figueras E, Borbely AN, Sewald N., J Pept Sci 23(7-8), 2017
PMID: 28661555
Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy.
Chen H, Lin Z, Arnst KE, Miller DD, Li W., Molecules 22(8), 2017
PMID: 28763044
Chen H, Lin Z, Arnst KE, Miller DD, Li W., Molecules 22(8), 2017
PMID: 28763044
Multivalency Increases the Binding Strength of RGD Peptidomimetic-Paclitaxel Conjugates to Integrin αV β3.
Raposo Moreira Dias A, Pina A, Dal Corso A, Arosio D, Belvisi L, Pignataro L, Caruso M, Gennari C., Chemistry 23(58), 2017
PMID: 28816404
Raposo Moreira Dias A, Pina A, Dal Corso A, Arosio D, Belvisi L, Pignataro L, Caruso M, Gennari C., Chemistry 23(58), 2017
PMID: 28816404
Bioconjugation - using selective chemistry to enhance the properties of proteins and peptides as therapeutics and carriers.
Gunnoo SB, Madder A., Org Biomol Chem 14(34), 2016
PMID: 27461374
Gunnoo SB, Madder A., Org Biomol Chem 14(34), 2016
PMID: 27461374
The cryptophycins as potent payloads for antibody drug conjugates.
Verma VA, Pillow TH, DePalatis L, Li G, Phillips GL, Polson AG, Raab HE, Spencer S, Zheng B., Bioorg Med Chem Lett 25(4), 2015
PMID: 25613677
Verma VA, Pillow TH, DePalatis L, Li G, Phillips GL, Polson AG, Raab HE, Spencer S, Zheng B., Bioorg Med Chem Lett 25(4), 2015
PMID: 25613677
Intramolecular Schmidt reaction of acyl chlorides with alkyl azides: preparation of pyrrolizine by intramolecular capture of intermediates with alkenes or alkynes.
Wang BJ, Xue P, Gu P., Chem Commun (Camb) 51(12), 2015
PMID: 25558477
Wang BJ, Xue P, Gu P., Chem Commun (Camb) 51(12), 2015
PMID: 25558477
Synthesis and biological evaluation of RGD peptidomimetic-paclitaxel conjugates bearing lysosomally cleavable linkers.
Dal Corso A, Caruso M, Belvisi L, Arosio D, Piarulli U, Albanese C, Gasparri F, Marsiglio A, Sola F, Troiani S, Valsasina B, Pignataro L, Pignataro L, Donati D, Gennari C., Chemistry 21(18), 2015
PMID: 25784522
Dal Corso A, Caruso M, Belvisi L, Arosio D, Piarulli U, Albanese C, Gasparri F, Marsiglio A, Sola F, Troiani S, Valsasina B, Pignataro L, Pignataro L, Donati D, Gennari C., Chemistry 21(18), 2015
PMID: 25784522
Design, characterization and cellular uptake studies of fluorescence-labeled prototypic cathepsin inhibitors.
Kohl F, Schmitz J, Furtmann N, Schulz-Fincke AC, Mertens MD, Küppers J, Benkhoff M, Tobiasch E, Bartz U, Bajorath J, Stirnberg M, Gütschow M., Org Biomol Chem 13(41), 2015
PMID: 26307943
Kohl F, Schmitz J, Furtmann N, Schulz-Fincke AC, Mertens MD, Küppers J, Benkhoff M, Tobiasch E, Bartz U, Bajorath J, Stirnberg M, Gütschow M., Org Biomol Chem 13(41), 2015
PMID: 26307943
Recent approaches for the synthesis of modified cryptophycins.
Weiss C, Sammet B, Sewald N., Nat Prod Rep 30(7), 2013
PMID: 23732943
Weiss C, Sammet B, Sewald N., Nat Prod Rep 30(7), 2013
PMID: 23732943
Peptides in receptor-mediated radiotherapy: from design to the clinical application in cancers.
Lozza C, Navarro-Teulon I, Pèlegrin A, Pouget JP, Vivès E., Front Oncol 3(), 2013
PMID: 24093086
Lozza C, Navarro-Teulon I, Pèlegrin A, Pouget JP, Vivès E., Front Oncol 3(), 2013
PMID: 24093086
Peptide conjugation via CuAAC 'click' chemistry.
Ahmad Fuaad AA, Azmi F, Skwarczynski M, Toth I., Molecules 18(11), 2013
PMID: 24284482
Ahmad Fuaad AA, Azmi F, Skwarczynski M, Toth I., Molecules 18(11), 2013
PMID: 24284482
References
Daten bereitgestellt von Europe PubMed Central.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 23387527
PubMed | Europe PMC
Suchen in